The U.S. Food and Drug Administration (FDA) approved six new therapies in December 2025 for blood cancers, prostate cancer, ...
The FDA has approved the first pill version of Wegovy, expanding access to one of the most popular and effective weight-loss ...
Vanda Pharmaceuticals said on Tuesday its drug for the prevention of motion-induced vomiting was approved by the U.S. health ...
Jefferies analysts envision a steady launch curve that could ultimately drive meaningful sales from people who are ...
The U.S. Food and Drug Administration on Dec. 22 approved a pill version of Novo Nordisk’s weight-loss drug Wegovy.
Long before memory problems appear, your brain may already be losing neurons. That is the unsettling message from new work by ...
Regulators at the U.S. Food and Drug Administration gave the green light to a pill version of the blockbuster weight-loss ...
The U.S. Food and Drug Administration has approved Omeros' drug for a dangerous transplant complication in adults and ...
Both Novo Nordisk’s and competitor Eli Lilly’s injectable GLP-1 drugs, Wegovy and Zepbound, have helped transform obesity ...
A fatty particle can clog arteries just as surely as cholesterol but often goes undetected, striking seemingly healthy people ...
Pharmaceutical Technology on MSN
FDA approves Vanda Pharmaceuticals’ motion sickness drug Nereus
The US Food and Drug Administration (FDA) has approved Vanda Pharmaceuticals’ Nereus (tradipitant) for the prevention of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback